Alaunos Therapeutics reported $1.88M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Alaunos Therapeutics USD 1.88M 1.08M Mar/2026
Amgen USD 95.64B 3.14B Jun/2026
AstraZeneca USD 115.83B 1.82B Jun/2026
Baxter International USD 19.79B 55M Jun/2026
Biogen USD 32.09B 2.6B Jun/2026
Bioline Rx USD 38.8M 2.11M Mar/2026
Bristol-Myers Squibb USD 87.63B 1.16B Jun/2026
Celltrion KRW 768.81B 9.37B Mar/2026
Corcept Therapeutics USD 888.7M 73.82M Jun/2026
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Curis USD 29.69M 9.72M Mar/2026
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Dianthus Therapeutics USD 1.21B 33.61M Jun/2026
Divis Laboratories Ltd INR 200.33B 18.82B Mar/2026
Gilead Sciences USD 49.36B 6.92B Jun/2026
GlaxoSmithKline GBP 61.74B 1.13B Jun/2026
Incyte USD 7.87B 533.53M Jun/2026
Intrexon USD 73.16M 77.88M Jun/2024
Ionis Pharmaceuticals USD 2.99B 455.5M Jun/2026
J&J USD 201.06B 167M Jun/2026
Kangmei Pharma CNY 13.31B 375.64M Mar/2026
Karyopharm Therapeutics USD 131.42M 23M Mar/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Merck USD 129.8B 1.12B Jun/2026
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Novartis USD 122.03B 3.5B Jun/2026
Organigram Holdings CAD 521.31M 9.36M Mar/2026
Ovoca Bio EUR 2.07M 414K Dec/2025
Pfizer USD 201.13B 6.49B Jun/2026
Pharma Mar EUR 393.6M 8.34M Jun/2026
PTC Therapeutics USD 3.25B 381.37M Jun/2026
Qiagen NV USD 5.89B 107.14M Jun/2026
Regeneron Pharmaceuticals USD 41.73B 861.8M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Sartorius EUR 9.6B 270.6M Jun/2026
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
TG Therapeutics USD 1.64B 110.79M Jun/2026
Tilray USD 2.1B 15.95M Sep/2025
Verastem USD 227.81M 18.63M Mar/2026
Zealand Pharma A/S 15.3B 647.8M Mar/2026
Zz Pientze Pharmaceu CNY 18.38B 905.93M Mar/2026